COVID-19 Vaccination is Associated With Favorable Outcomes Among Lung Transplant Patients With Breakthrough Infections

BACKGROUND: There are limited data regarding the clinical efficacy of COVID-19 vaccines among lung transplant (LT) patients. METHODS: We included all LT patients diagnosed with COVID-19 between March 1, 2020, and December 10, 2021 (n = 84; median age 55, range, 20-73 years; males 65.5%). The study g...

Descripción completa

Detalles Bibliográficos
Autores principales: Bollineni, Srinivas, Mahan, Luke D., Lawrence, Adrian, Joerns, John, Timofte, Irina, Torres, Fernando, Kaza, Vaidehi, La Hoz, Ricardo M., SoRelle, Jeffrey A., Kershaw, Corey D., Terada, Lance S., Zhang, Song, Mohanka, Manish R., Banga, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197779/
https://www.ncbi.nlm.nih.gov/pubmed/35909014
http://dx.doi.org/10.1016/j.transproceed.2022.05.030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197779/
https://www.ncbi.nlm.nih.gov/pubmed/35909014
http://dx.doi.org/10.1016/j.transproceed.2022.05.030

Ejemplares similares